[1]
|
Dobrewa, W., Bielska, M., Bąbol-Pokora, K., Janczar, S. and Młynarski, W. (2024) Congenital Neutropenia: From Lab Bench to Clinic Bedside and Back. Mutation Research—Reviews in Mutation Research, 793, Article ID: 108476. https://doi.org/10.1016/j.mrrev.2023.108476
|
[2]
|
孟新, 侯佳, 张萍, 等. 先天性中性粒细胞减少症研究进展[J]. 中国循证儿科杂志, 2018, 13(4): 310-318.
|
[3]
|
López-Rodríguez, L., Svyryd, Y., Benítez-Alonso, E.O., Rivero-García, P., Luna-Muñoz, L. and Mutchinick, O.M. (2022) Severe Congenital Neutropenia Type 4: A Rare Disease Harboring a g6pc3 Gene Pathogenic Variant Particular to the Mexican Population. Revista de Investigacin Clnica, 74, 328-339. https://doi.org/10.24875/ric.22000234
|
[4]
|
Dobrewa, W., Madzio, J., Babol‐Pokora, K., Lopacz, P., Gierszon, A., Guz, K., et al. (2023) A High Prevalence of Neutrophil‐Specific Antibodies in Elane‐Mutated Severe Congenital Neutropenia. Pediatric Blood & Cancer, 70, e30247. https://doi.org/10.1002/pbc.30247
|
[5]
|
Nasri, M., Ritter, M.U., Mir, P., Dannenmann, B., Kaufmann, M.M., Arreba-Tutusaus, P., et al. (2024) Crispr-cas9n-Mediated ELANE Promoter Editing for Gene Therapy of Severe Congenital Neutropenia. Molecular Therapy, 32, 1628-1642. https://doi.org/10.1016/j.ymthe.2024.03.037
|
[6]
|
Çipe, F.E., Aydoğmuş, Ç., Baskın, K., Keskindemirci, G., Garncarz, W. and Boztuğ, K. (2020) A Rare Case of Syndromic Severe Congenital Neutropenia: JAGN1 Mutation. The Turkish Journal of Pediatrics, 62, 326-331. https://doi.org/10.24953/turkjped.2020.02.022
|
[7]
|
Boztug, K., Järvinen, P.M., Salzer, E., Racek, T., Mönch, S., Garncarz, W., et al. (2014) JAGN1 Deficiency Causes Aberrant Myeloid Cell Homeostasis and Congenital Neutropenia. Nature Genetics, 46, 1021-1027. https://doi.org/10.1038/ng.3069
|
[8]
|
Dale, D.C. and Welte, K. (2010) Cyclic and Chronic Neutropenia. In: Lyman, G.H. and Dale, D.C., Eds., Cancer Treatment and Research, Springer US, 97-108. https://doi.org/10.1007/978-1-4419-7073-2_6
|
[9]
|
Wen, L.Y., Ma, X., Peng, H.F., et al. (2023) Neutrophil Elastase Gene Mutation-Induced Cyclic Neutropenia: A Case Report. Chinese Journal of Internal Medicine, 62, 193-196.
|
[10]
|
Liu, Y., Fu, J. and Guan, X.B. (2020) Cyclic Neutropenia: A Case Report. Chinese Journal of Stomatology, 55, 264-265.
|
[11]
|
Liu, H., Liu, G., Zhao, P., et al. (2020) Clinical and Genetic Analysis of Two Patients with Congenital Neutropenia Caused by ELANE Gene Mutation. Chinese Journal of Medical Genetics, 37, 1097-1101.
|
[12]
|
Sabo, P., Makaryan, V., Dicken, Y., Povodovski, L., Rockah, L., Bar, T., et al. (2022) Mutant Allele Knockout with Novel CRISPR Nuclease Promotes Myelopoiesis in ELANE Neutropenia. Molecular Therapy-Methods & Clinical Development, 26, 119-131. https://doi.org/10.1016/j.omtm.2022.06.002
|
[13]
|
Shinwari, K., Bolkov, M.A., Yasir Akbar, M., Guojun, L., Deryabina, S.S., Tuzankina, I.A., et al. (2022) In Silico Analysis Revealed Five Novel High-Risk Single-Nucleotide Polymorphisms (Rs200384291, Rs201163886, Rs193141883, Rs201139487, and Rs201723157) in ELANE Gene Causing Autosomal Dominant Severe Congenital Neutropenia 1 and Cyclic Hematopoiesis. The Scientific World Journal, 2022, Article ID: 3356835. https://doi.org/10.1155/2022/3356835
|
[14]
|
Tran, N.T., Graf, R., Wulf-Goldenberg, A., Stecklum, M., Strauß, G., Kühn, R., et al. (2020) Crispr-cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia. Molecular Therapy, 28, 2621-2634. https://doi.org/10.1016/j.ymthe.2020.08.004
|
[15]
|
Acar, B., Cagdas, D., Tan, Ç., Özbek, B., Yaz, İ., Yıldırım, Y.D., et al. (2020) Evaluation of Periodontal Status and Cytokine/Chemokine Profile of GCF in Patients with Severe Congenital Neutropenia. Odontology, 109, 474-482. https://doi.org/10.1007/s10266-020-00565-1
|
[16]
|
Oved, J.H., Gibson, N.M., Venella, K., Elgarten, C.W., Wray, L., Warren, J.T., et al. (2024) Reduced Toxicity Matched Sibling Bone Marrow Transplant Results in Excellent Outcomes for Severe Congenital Neutropenia. Frontiers in Immunology, 15, Article 1369243. https://doi.org/10.3389/fimmu.2024.1369243
|
[17]
|
Mehta, H.M. and Corey, S.J. (2021) G-CSF, the Guardian of Granulopoiesis. Seminars in Immunology, 54, Article ID: 101515. https://doi.org/10.1016/j.smim.2021.101515
|
[18]
|
Nasri, M., Dannenmann, B., Doll, L., Findik, B., Bernhard, F., Kandabarau, S., et al. (2024) Flavopiridol Restores Granulopoiesis in Experimental Models of Severe Congenital Neutropenia. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.10.031
|
[19]
|
Horwitz, M.S. (2021) Neutrophil Elastase: Nonsense Lost in Translation. Cell Stem Cell, 28, 790-792. https://doi.org/10.1016/j.stem.2021.04.007
|
[20]
|
Rao, S., Yao, Y., Soares de Brito, J., Yao, Q., Shen, A.H., Watkinson, R.E., et al. (2021) Dissecting ELANE Neutropenia Pathogenicity by Human HSC Gene Editing. Cell Stem Cell, 28, 833-845.e5. https://doi.org/10.1016/j.stem.2020.12.015
|
[21]
|
Zhu, H., Liao, Q., Gong, Y., et al. (2020) Clinical and Genetic Analysis of Four Patients with Congenital Neutropenia. Chinese Journal of Medical Genetics, 37, 1222-1225.
|
[22]
|
Dannenmann, B. and Skokowa, J. (2022) Generation, Expansion, and Drug Treatment of Hematopoietic Progenitor Cells Derived from Human IPSCS. STAR Protocols, 3, Article ID: 101400. https://doi.org/10.1016/j.xpro.2022.101400
|